Physician

Daniel Olson, M.D.

According to 2025 Medicare claims, Daniel Olson, M.D. (NPI: 1003234329) practices hematopoietic cell transplantation and cellular therapy in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is THE UNIVERSITY OF CHICAGO MEDICAL CENTER (NPI: 1033218128; TIN: 36-3488183) and primary practice location at 60637-1447. Olson is affiliated with the CHA ACO, LLC (ACO ID: A2207) and UCMCNACO, LLC (ACO ID: A3531), participating under the MSSP model.

Olson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 173 traditional Medicare patients, billed 688 HCPCS/CPT codes, and received $62,434 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 160 prescription claims across 44 beneficiaries totaling $313,730 in drug costs, led by Imatinib Mesylate (Imatinib Mesylate). Open Payments data shows 7 records totaling $105,434. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $5,708 and ending at $62,434. Concurrently, Part D prescription costs have risen steadily, from $10,765 to $313,730. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	30	67	$5,708
2021	63	182	$20,163
2022	205	681	$73,636
2023	147	367	$40,142
2024	173	688	$62,434

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	37	137	$10,765
2016	25	241	$11,980
2017	42	206	$18,741
2018	29	73	$3,404
2019	19	52	$2,769
2020	27	68	$131,038
2021	22	125	$731,537
2022	42	132	$569,000
2023	43	119	$237,735
2024	44	160	$313,730

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	53	53	$155
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	63	193	$125
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	38	135	$100
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	48	92	$81
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	62	142	$15

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imatinib Mesylate	Imatinib Mesylate	12	480	$1,539
Levothyroxine Sodium	Levothyroxine Sodium	32	1,691	$288

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$3,930	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	5	$101,504	Merck Sharp & Dohme LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel Olson, M.D.?

Tedicare shows public-source Medicare data for Daniel Olson, M.D. (NPI 1003234329), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Olson, M.D. have ACO affiliation data?

Daniel Olson, M.D. is shown with ACO affiliation data for CHA ACO, LLC (MSSP, ACO ID A2207) and UCMCNACO, LLC (MSSP, ACO ID A3531).

What billing organization is linked to Daniel Olson, M.D.?

Daniel Olson, M.D. is linked to THE UNIVERSITY OF CHICAGO MEDICAL CENTER (billing NPI 1033218128) in the available physician profile data.

Does Daniel Olson, M.D. have Open Payments data?

Daniel Olson, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.